Multiparameter Monitors in Washington

Inmedix, Inc. is a Washington-based medical diagnostics company specializing in autonomic nervous system (ANS) assessment through heart rate variability (HRV) analysis. The company manufactures the CloudHRV System, an FDA-cleared clinical diagnostic device that provides medical-grade, 5-minute HRV testing to evaluate both sympathetic (fight-or-flight) and parasympathetic (rest/restorative) neuroregulatory function. The CloudHRV System received FDA clearance in 2025 and is currently deployed across multiple states (Washington, Oregon, Michigan, Florida) with coverage by most major insurance plans. The platform is designed to support precision diagnostics by quantifying autonomic nervous system function, with applications in cardiology and general internal medicine. Inmedix emphasizes the clinical and diagnostic value of HRV measurement and has completed over 1,000 procedures since July 2024. The company's scientific approach focuses on immuno-autonomics and the pathophysiological significance of ANS dysfunction in disease assessment and patient stratification.

Wisonic Medical Technology (华声医疗) is a China-headquartered medical device company specializing in ultrasound systems and cloud-enabled clinical solutions. The company designs and manufactures specialty ultrasound platforms across multiple clinical domains: general bedside ultrasound, obstetric/gynecological ultrasound, anesthesia and pain management ultrasound, critical care ultrasound, musculoskeletal/rehabilitation ultrasound, veterinary ultrasound, and fetal monitoring systems. Primary product lines include Lotus (screening ultrasound), Polaris/Labat/Navi (anesthesia/pain), Clivia/Clover (bedside), Sunflower/Carnation (critical care), Piloter (rehabilitation), Apus (veterinary), and Lavender/Mugwort (patient monitoring/bedside monitors). The company also develops cloud-based telemedicine and remote consultation capabilities, PACS software (华声云PACS), intelligent quality control systems for ultrasound imaging, and data asset services. Wisonic holds CFDA (China FDA) approvals for multiple products and maintains ISO 13485 certification. The company operates a global distribution and service network spanning 100+ countries with presence in 3,000+ hospitals. Wisonic maintains R&D partnerships with leading universities (Tsinghua, Tongji, Michigan State) and has received national high-tech enterprise status and specialist/champion manufacturing designation from Chinese authorities. Training and clinical education are core competencies, with annual workshops and the "Dandelion Academy" cloud learning platform serving 120,000+ trained clinicians globally.

Fukuda Denshi USA, Inc. is the North American subsidiary of Fukuda Denshi, a global manufacturer of integrated patient monitoring, diagnostic cardiology, and digital health solutions for acute care, general care, and ambulatory settings. The company specializes in bedside and central station patient monitoring systems, including multiparameter monitors (vital signs, ECG, blood pressure, oxygen saturation), portable monitoring devices, and diagnostic cardiology/vascular testing equipment (ECG, stress testing systems, echocardiography systems). Fukuda's product portfolio includes the DS-1800 Central Station and LXN-1000 series portable monitors designed for flexible deployment across clinical workflows. The company also offers interoperability and digital health solutions that integrate with existing hospital information systems and EHRs, emphasizing configurable, seamless integration without requiring workflow changes. Fukuda maintains a support infrastructure including technical support, training, and field service capabilities. Products are designed for hospital acute care units, ICUs, general care floors, and outpatient diagnostic labs. The company emphasizes ease of use, installation simplicity, and cost-effectiveness. Service capabilities include training programs and technical support accessible via phone and online support center.